Aktar Mert
SEC CIK 2040256 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | Dir | 21.7K | — | — | 2 | 2025-05-29 | 2026-05-27 |
Most active insiders at KYTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Westlake BioPartners Opportunity Fund I, L.P. | 10% | $1000.0K | — |
| 2 | SEIDENBERG BETH C | Dir | $1000.0K | — |
| 3 | Walker Karen Marie | CTO | — | $292.8K |
| 4 | GEHCHAN NAJI | See Remarks | — | — |
| 5 | Aktar Mert | Dir | — | — |
| 6 | Biddle Warner Weston | CEO, Dir | — | — |
| 7 | Emany Sravan Kumar | Dir | — | — |
| 8 | Miller Andrew Craig | Dir | — | — |
| 9 | GRASSO MARC | CFO | — | — |
| 10 | Shaw Christi | Executive COB, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-29 16:30 | 2026-05-27 | KYTX | Kyverna Therapeutics, Inc. | Aktar Mert | Dir | A - Grant | $0.00 | +5,093 | 21.7K | +31% | $0 |
| D | 2025-06-02 | 2025-05-29 | KYTX | Kyverna Therapeutics, Inc. | Aktar Mert | Dir | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations